Radiological.ai
All posts
Industry

PowerScribe 360 End of Life: What Radiology Groups Should Do

Microsoft is retiring PowerScribe 360 and ending renewal and maintenance in August 2026, directing customers to PowerScribe One on a subscription. What is changing, what your options are, and what to evaluate before you sign.

By the Radiological.ai team

July 2026 · 9 min read

The Reading Station

Worklist

SERIES 1 · AX
SLICE 24/64
SAMPLE STUDY
NOT FOR DIAGNOSTIC USE
W 80 · L 40
ILLUSTRATIVE SAMPLE

Structured report

Draft

Run the assistant to draft this report for review.

You review & sign

Illustrative sample · not a real patient study, not a diagnosis

Drafted in · you review & sign Worklist re-prioritized

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.

The short answer: Microsoft is retiring PowerScribe 360, the on-premises radiology reporting product it acquired with Nuance, and ending its renewal and maintenance in August 2026. The upgrade path is PowerScribe One, a cloud-based version sold on a subscription. Groups that bought and owned the on-premises software will move to recurring payments. Because a migration is now unavoidable, this is the natural moment to ask whether your reporting tool should do more than capture dictation.

Customers started receiving end-of-life notices in late February 2026. If you run PowerScribe 360, you have probably already had the conversation internally, and it is not a comfortable one: an unplanned project, a new cost structure, and a timeline you did not choose. This piece lays out what is actually changing, what your real options are, and the questions worth asking before you sign anything.

What exactly is being retired?

PowerScribe 360 is the on-premises radiology reporting and dictation platform. It came from Nuance, which Microsoft acquired and folded into its healthcare division. Microsoft has told customers that renewal and maintenance for PowerScribe 360 end in August 2026, and it is directing those customers to PowerScribe One, its cloud-based reporting platform, available on a subscription basis.

The important distinction is between the product being switched off and the commercial model changing. Practically, both are happening at once for most groups:

What changesPowerScribe 360 (today)PowerScribe One (the path)
Where it runsOn-premises, on your serversCloud-based
How you payPurchased, with maintenanceSubscription, recurring
Support statusRenewal and maintenance end August 2026The supported product going forward
Migration workNot optional if you stay supportedTemplates, integrations, training

Confirm your own dates directly with Microsoft. Contract terms differ, and a date that is firm for one group can sit differently for another depending on what was signed and when.

Is PowerScribe 360 being discontinued?

Yes, in the sense that matters to you. Renewal and maintenance end in August 2026, which means no continued support path on the on-premises product. Software that still runs but is no longer maintained is a liability in a clinical environment, particularly one handling protected health information, because security patching stops being someone else's job and quietly becomes yours.

So "we will just keep running it" is not a real long-term option, even if the binaries keep working. Running unmaintained clinical software is a decision your compliance and security people will want a say in, and they will be right to.

What is replacing PowerScribe 360?

Microsoft's answer is PowerScribe One, the cloud-based successor, on a subscription. For many groups that will be the path of least resistance, and there is nothing wrong with choosing it. Your radiologists know the product family, your templates have a migration route, and the vendor relationship already exists.

What deserves a moment of thought is the shift in the economics. If your group purchased PowerScribe 360 outright, you owned an asset and paid maintenance on it. Moving to a subscription converts that into an ongoing operating cost that recurs for as long as you read studies. That is not automatically worse, and cloud delivery brings real benefits in patching, uptime and update cadence. But it is a genuinely different financial commitment, and it is worth pricing properly rather than treating it as a formality.

Do we have to migrate to PowerScribe One?

No. You have to migrate to something, which is a different statement. The forced-move moment is the one time in a decade when the switching cost of leaving is roughly the same as the cost of staying, because you are doing the template, integration and training work either way. That symmetry is unusual and it is worth using.

Broadly, three paths are open:

  • Move to PowerScribe One. The lowest-friction option. Familiar product family, a supported migration route, and a vendor you already have on paper.
  • Move to another reporting platform. Several radiology reporting products compete here, and a forced migration is when they get a fair hearing. You will do the integration work regardless, so the question becomes which destination is worth the same effort.
  • Ask what else the reporting tool should do. Reporting is one part of the read. If you are rebuilding templates and retraining radiologists anyway, this is the cheapest opportunity you will get to also fix worklist triage and finding flags.

What should we actually evaluate?

Dictation quality is table stakes at this point. Every serious product in this category turns speech into a structured report competently. The differences that will matter to your group in two years are elsewhere.

When does the assist begin?

A dictation platform starts helping once you are already reading and already talking. Everything before that, deciding which study to read next, noticing the subtle finding on the hundredth chest film of the shift, is still entirely on the radiologist. A tool that begins at the worklist instead of at the microphone changes the shape of the day rather than just the speed of typing. That is the design behind our AI radiology reporting approach: the structured report is drafted from the study before dictation starts, so you edit a draft rather than compose from an empty template.

Does it flag anything, or only transcribe?

Transcription converts your judgment into text. It does not offer a second look. A decision-support assistant that flags suspected findings for review on every study gives you a consistent prompt to look again, which is worth most exactly when a human is least able to provide it, late in a long list. The radiologist confirms or dismisses every flag and signs every study, so judgment stays where it belongs.

Does it sort the queue?

Worklist prioritization is the piece groups most often discover they wanted only after they have bought a reporting-only tool. If a suspected critical study is sitting behind forty routine follow-ups, no amount of dictation speed fixes that. Our worklist prioritization page covers how the re-sorting works in practice.

How does it integrate?

Ask this early and get it in writing. A tool that requires a second login, a separate monitor, or copy and paste between windows will be abandoned by your radiologists inside a month regardless of how good the underlying model is. The integration questions that matter are covered on our radiology AI PACS integration page: how studies reach the tool, how results come back into the viewer you already use, and how priority and report drafts reach the RIS.

How much will the migration actually cost?

The subscription line item is the part everyone looks at, and it is rarely the largest cost. The full picture includes template rebuilding, integration work against your PACS and RIS, the security and compliance review, and radiologist training time, which is the most expensive hour in the building and the one most often left out of the spreadsheet.

Two practical suggestions. First, price the whole migration and not just the license, then compare that total against the same total for any alternative you consider. The license gap between two products is often smaller than the difference in integration effort. Our breakdown of what drives radiology AI cost goes through the line items in detail.

Second, use the moment to get your vendor paperwork in order. A forced end-of-life is usually the point at which a practice discovers nobody was watching the renewal dates, auto-renew clauses and support commitments sitting in its software contracts. If yours are scattered across inboxes and a shared drive, it is worth putting the obligations and renewal dates buried in those contracts somewhere they will be seen before the next surprise notice, not after.

What is the difference between PowerScribe and Dragon?

This comes up constantly during migration planning, so it is worth settling. Both originated at Nuance and both now sit under Microsoft. Dragon is general-purpose speech recognition, used across medicine and well beyond it. PowerScribe is the radiology-specific reporting platform, built around structured templates, the worklist and the radiology reporting workflow. When a radiology group says "our dictation system," they nearly always mean PowerScribe.

DAX, which you may also see referenced, is a third thing again: ambient documentation that listens to a patient encounter and drafts the clinical note from the conversation. It is genuinely useful in clinic settings. It has little to grip in diagnostic radiology, where the radiologist reads a study alone and there is no conversation to capture. We cover that distinction on our Nuance DAX alternative page.

A sensible plan for the next few months

  1. Confirm your dates in writing. Get your specific end-of-renewal date from Microsoft rather than relying on a summary, including this one.
  2. Cost the full migration, not the license. Templates, integration, security review, and radiologist training hours.
  3. Take two or three real demos. The switching cost is already sunk. Use it. Have vendors demo on your study mix, not theirs.
  4. Decide what the tool should do beyond dictation. Flagging and worklist triage are far cheaper to add during a migration you are already doing than in a separate project next year.
  5. Run a shadow period. Whatever you choose, let it run without changing the worklist first, so your radiologists can watch its behavior on their own studies before it affects anything.

A forced migration is nobody's idea of a good quarter. But the work is happening either way, and the one benefit of being pushed is that the usual reason for not evaluating alternatives, that switching is too disruptive, has already evaporated. Ask for more from the tool this time.

If you have to rebuild the templates, retrain the radiologists and redo the integrations anyway, the marginal cost of evaluating a better destination is close to zero. That is not true in any other year.

Radiological.ai flags suspected findings for review, prioritizes the worklist so urgent studies surface first, and drafts the structured report into your template before you dictate, across X-ray, CT and MRI. It is decision support, not a diagnosis, and the responsible radiologist reviews, edits and signs every study. If PowerScribe 360 has put a migration on your desk, see the PowerScribe alternative comparison or what it costs.

See Radiological.ai read a study

The assistant flags suspected findings for review, prioritizes the worklist so urgent studies surface first, and drafts the structured report into your template. You review, edit and sign every study.

Bring the assistant to your reading workflow

Radiological.ai flags suspected findings, prioritizes the worklist and drafts the structured report across X-ray, CT and MRI, in one calm pane. The responsible radiologist reviews, edits and signs every study.

X-ray, CT & MRI · Flag, triage, draft · You review & sign

Radiological.ai is a workflow and decision-support tool for qualified clinicians. It does not provide a diagnosis and is not a substitute for professional medical judgment.